Dementia in Malta: new prevalence estimates and projected trends

Scerri, Anthony; Scerri, Charles
September 2012
Malta Medical Journal;2012, Vol. 24 Issue 3, p21
Academic Journal
Previous estimates have indicated that in 2005, there were 4,072 individuals with dementia (IWD) in the Maltese islands and that this number would almost double by the year 2050. These figures were based on the EURODEM project that analysed the results of a population-based systematic review of published studies on the global prevalence of dementia from 1980 to 2004. Since then, further dementia prevalence studies have been carried out in Europe. These were reviewed in another European funded project, the EUROCODE project, with the aim of developing consensual European age and gender specific prevalence rates that would be acceptable for all countries. Using these revised rates, the estimated number of IWD over 60 years of age in the Maltese islands in 2010 was found to be 5,198; a significant increase on previous projected data. Likewise, the number of IWD in Malta over 60 years in 2030 is projected to be close to 10,000 persons or 2.3% of the total Maltese population. Using these revised estimates, the 2% prevalence rate of dementia among the local population is expected to be reached by 2025; twenty-five years prior to what was previously reported. The data presented here include current updated estimates and projections for the number of IWD in the Maltese islands.


Related Articles

  • The Ekman 60 Faces Test as a diagnostic instrument in frontotemporal dementia. Diehl-Schmid, Janine; Pohl, Corina; Ruprecht, Carolin; Wagenpfeil, Stefan; Foerstl, Hans; Kurz, Alexander // Archives of Clinical Neuropsychology;May2007, Vol. 22 Issue 4, p459 

    Abstract: Frontotemporal dementia (FTD) is characterized by dramatic changes of personality and behaviour. Impaired ability of emotional processing could contribute to these symptoms, as it may lead to misinterpretation of emotional cues that would normally guide behaviour. The aim of the...

  • Lipid Peroxidation and Antioxidant Enzyme Activities in Vascular and Alzheimer Dementias. Ãngela Casado; Mª Encarnación López-Fernández; Mª Concepción Casado; Rosario de La Torre // Neurochemical Research;Mar2008, Vol. 33 Issue 3, p450 

    Abstract  It has been reported that oxidative stress may play a role in the pathogenesis of dementia of the Alzheimer type (AD) and the cerebral ischemia which causes vascular dementia (VD). We measured malondialdehyde (MDA) levels and superoxide dismutase (SOD), catalase (CAT),...

  • Progression of Mild Cognitive Impairment to Alzheimer's or Vascular Dementia Versus Normative Aging Among Elderly Chinese. Juebin Huang; Meyer, John Stirling; Zhenxin Zhang; Jing Wei; Xia Hong; Jianmin Wang; Hongbo Wen; Wenjie Wu; Jixing Wu; Chowdhury, Munir H. // Current Alzheimer Research;Dec2005, Vol. 2 Issue 5, p571 

    To compare differences in evolutionary progressions from Mild Cognitive Impairment (MCI) to dementia of Alzheimer's type (DAT) or to vascular dementia (VaD) versus normal aging, subjects identified as MCI or as cognitively normal (CN) during standard cognitive evaluations among a large...

  • Psychosocial Factors That Shape Patient and Carer Experiences of Dementia Diagnosis and Treatment: A Systematic Review of Qualitative Studies. Bunn, Frances; Goodman, Claire; Sworn, Katie; Rait, Greta; Brayne, Carol; Robinson, Louise; McNeilly, Elaine; Iliffe, Steve // PLoS Medicine;Oct2012, Vol. 9 Issue 10, p1 

    Background: Early diagnosis and intervention for people with dementia is increasingly considered a priority, but practitioners are concerned with the effects of earlier diagnosis and interventions on patients and caregivers. This systematic review evaluates the qualitative evidence about how...

  • Diagnosing dementia with confidence by GPs. Hein PJ van Hout; Myrra J Vernooij-Dassen; Wim AB Stalman // Family Practice;Dec2007, Vol. 24 Issue 6, p616 

    Background. Earlier reports suggest limited clinical reasoning and substantial uncertainty of GPs in assessing patients suspected of dementia. Objective. To explore the predictors of GPs to decide on the presence and absence of dementia as well as the predictors of diagnostic confidence of GPs....

  • Outcome in subgroups of mild cognitive impairment (MCI) is highly predictable using a simple algorithm. Mitchell, Joanna; Arnold, Robert; Dawson, Kate; Nestor, Peter J.; Hodges, John R. // Journal of Neurology;Sep2009, Vol. 256 Issue 9, p1500 

    Although it is well recognized that MCI represents a risk state for subsequent dementia, estimates of conversion vary widely according to the diagnostic criteria employed. There are currently no simple cognitive predictors of high and low risk of progression. We followed 107 non-demented...

  • Participation in physical and social activities among home-dwelling persons with dementia - experiences of next of kin. Söderhamn, Ulrika; Landmark, Bjørg; Eriksen, Sissel; Söderhamn, Olle // Psychology Research & Behavior Management;2013, Vol. 6, p29 

    Introduction: To be next of kin to a home-dwelling person with dementia is known to be a heavy burden, especially early in the process. Studies have revealed a need for information and support during the disease process. Likewise, there is support for the positive impacts of physical and social...

  • The best of times. Wallis, Lynne // Nursing Standard;8/27/2008, Vol. 22 Issue 51, p20 

    Reminiscence therapy is a popular way to engage people with dementia, but there is little evidence of its efficacy. Researchers are carrying out a randomised controlled trial of reminiscence therapy for people with dementia to ascertain its effects on patients and carers.

  • Rapidly-administered short forms of the Wechsler Adult Intelligence Scale—3rd edition Donnell, Alison J.; Pliskin, Neil; Holdnack, James; Axelrod, Bradley; Randolph, Christopher // Archives of Clinical Neuropsychology;Nov2007, Vol. 22 Issue 8, p917 

    Abstract: Although the Wechsler Full Scale IQ (FSIQ) is a common component of most neuropsychological evaluations, there are many clinical situations where the complete administration of this battery is precluded by various constraints, including limitations of time and patient compliance. These...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics